Regenxbio Inc (RGNX)
9.935
+0.38
(+4.03%)
USD |
NASDAQ |
Nov 27, 13:29
Regenxbio Shares Outstanding: 49.55M for Oct. 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 31, 2024 | 49.55M |
September 30, 2024 | 49.53M |
July 25, 2024 | 49.42M |
June 30, 2024 | 49.32M |
May 02, 2024 | 49.26M |
April 01, 2024 | 49.04M |
March 31, 2024 | 49.04M |
March 11, 2024 | 48.99M |
February 22, 2024 | 44.43M |
December 31, 2023 | 44.05M |
November 02, 2023 | 43.99M |
September 30, 2023 | 43.99M |
August 30, 2023 | 43.96M |
July 27, 2023 | 43.96M |
July 07, 2023 | 43.88M |
June 30, 2023 | 43.62M |
April 27, 2023 | 43.47M |
April 03, 2023 | 43.47M |
March 31, 2023 | 43.46M |
February 23, 2023 | 43.46M |
December 31, 2022 | 43.30M |
October 27, 2022 | 43.29M |
September 30, 2022 | 43.29M |
July 27, 2022 | 43.23M |
June 30, 2022 | 43.17M |
Date | Value |
---|---|
April 28, 2022 | 43.13M |
April 04, 2022 | 42.99M |
March 31, 2022 | 42.98M |
February 24, 2022 | 42.95M |
December 31, 2021 | 42.83M |
October 28, 2021 | 42.77M |
September 30, 2021 | 42.75M |
August 04, 2021 | 42.60M |
June 30, 2021 | 42.56M |
April 30, 2021 | 42.51M |
April 05, 2021 | 42.51M |
March 31, 2021 | 42.50M |
February 25, 2021 | 42.50M |
January 12, 2021 | 42.38M |
December 31, 2020 | 37.48M |
October 30, 2020 | 37.41M |
September 30, 2020 | 37.40M |
July 31, 2020 | 37.33M |
June 30, 2020 | 37.29M |
May 01, 2020 | 37.24M |
March 31, 2020 | 37.19M |
March 30, 2020 | 37.19M |
February 21, 2020 | 37.14M |
December 31, 2019 | 36.99M |
November 01, 2019 | 36.87M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
36.99M
Minimum
Dec 31 2019
49.55M
Maximum
Oct 31 2024
43.00M
Average
43.17M
Median
Jun 30 2022
Shares Outstanding Benchmarks
Catalyst Pharmaceuticals Inc | 119.27M |
EyePoint Pharmaceuticals Inc | 68.25M |
Cassava Sciences Inc | 48.11M |
Vertex Pharmaceuticals Inc | 257.53M |
Sarepta Therapeutics Inc | 95.52M |